Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods and compositions for treating cancer

A composition and cancer technology, applied in the field of glucocorticoids and cancer treatment, can solve problems such as treatment does not show significant response, does not show response, cancer regression or recurrence

Inactive Publication Date: 2015-01-28
库伽尔生物科技公司
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Although hormone therapy is less invasive and can be used in more advanced stages of cancer, some individuals receiving current hormone therapy treatments do not show a significant response or any response to this treatment
Additionally, some patients treated with current hormone therapy may also experience cancer regression or recurrence
Currently, patients with this difficult-to-treat cancer have few treatment options

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for treating cancer
  • Methods and compositions for treating cancer
  • Methods and compositions for treating cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] The method of treating cancer described herein comprises administering to a mammal, preferably a human, 17α-hydroxylase / C 17，20 - a lyase inhibitor and at least one therapeutic agent, such as an anticancer agent or a steroid, especially a glucocorticoid. The compositions described herein comprise 17α-hydroxylase / C 17，20 - a lyase inhibitor and at least one additional therapeutic agent, such as an anticancer agent or a steroid, especially a corticosteroid or a glucocorticoid. Other anticancer therapies, such as administration of another anticancer agent, radiation therapy, chemotherapy, photodynamic therapy, surgery, or other immunotherapy, can be used with the methods and compositions.

[0037] 17α-Hydroxylase / C 17，20 - Lyase inhibitors

[0038] 17α-Hydroxylase / C 17，20 - Lyase inhibitors have been shown to be useful in cancer therapy, particularly in the treatment of hormone-dependent disorders, such as androgen-dependent disorders and estrogen-dependent disorders, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Methods and compositions for treating cancer are described herein. More particularly, the methods for treating cancer comprise administering a 17±-hydroxylase / C 17,20 -lyase inhibitor, such as abiraterone acetate (i.e., 3²-acetoxy-17-(3-pyridyl) androsta-5, 16-diene), in combination with at least one additional therapeutic agent such as an anti-cancer agent or a steroid. Furthermore, disclosed are compositions comprising a 17±-hydroxylase / C 17,20 -lyase inhibitor, and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid.

Description

[0001] This application is a divisional application of the invention patent application with the application number "200780038583.5" and the invention title "Method and Composition for Treating Cancer". technical field [0002] Methods and compositions for treating cancer are described herein. More specifically, the method for treating cancer includes 17α-hydroxylase / C 17，20 - a lyase inhibitor, such as abiraterone acetate (i.e. 3β-acetoxy-17-(3-pyridyl)androst-5,16-diene), and at least one additional therapeutic agent, such as an anticancer drug or steroid combination. In addition, compositions are disclosed comprising 17α-hydroxylase / C 17，20 - a lyase inhibitor, and at least one additional therapeutic agent, such as an anticancer agent or a steroid, such as a corticosteroid, or more particularly a glucocorticoid. Background technique [0003] The number of people diagnosed with cancer has increased significantly. Of particular concern are individuals diagnosed with and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K31/58A61K31/573A61P35/00
CPCA61K31/58A61K31/573A61K45/06A61P35/00A61K2300/00A61K9/20A61K9/48A61K31/337A61K31/568
Inventor 艾伦.H.奥尔巴克阿里.S.贝尔德格伦
Owner 库伽尔生物科技公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com